Novozymes As Stock Analysis
| NVZMY Stock | USD 58.24 0.78 1.32% |
Novozymes AS is overvalued with Real Value of 51.2 and Hype Value of 58.24. The main objective of Novozymes pink sheet analysis is to determine its intrinsic value, which is an estimate of what Novozymes AS is worth, separate from its market price. There are two main types of Novozymes' stock analysis: fundamental analysis and technical analysis.
The Novozymes pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Novozymes |
Novozymes Pink Sheet Analysis Notes
The company last dividend was issued on the 6th of March 2023. Novozymes AS had 5:1 split on the 9th of December 2011. Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes Unspn is traded on OTC Exchange in the United States.The quote for Novozymes AS is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Novozymes AS contact Ester Baiget at 45 44 46 00 00 or learn more at https://www.novozymes.com.Novozymes AS Investment Alerts
| Novozymes AS generated a negative expected return over the last 90 days |
Novozymes Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 14.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novozymes's market, we take the total number of its shares issued and multiply it by Novozymes's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Novozymes Profitablity
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26.Technical Drivers
As of the 4th of December, Novozymes secures the Risk Adjusted Performance of (0.13), mean deviation of 1.04, and Standard Deviation of 1.45. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novozymes AS, as well as the relationship between them.Novozymes AS Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Novozymes middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Novozymes AS. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Novozymes Outstanding Bonds
Novozymes issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Novozymes AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Novozymes bonds can be classified according to their maturity, which is the date when Novozymes AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Novozymes Predictive Daily Indicators
Novozymes intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Novozymes pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Novozymes Forecast Models
Novozymes' time-series forecasting models are one of many Novozymes' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novozymes' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Novozymes Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Novozymes prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novozymes shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Novozymes. By using and applying Novozymes Pink Sheet analysis, traders can create a robust methodology for identifying Novozymes entry and exit points for their positions.
Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Novozymes Unspn is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Novozymes to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Additional Tools for Novozymes Pink Sheet Analysis
When running Novozymes' price analysis, check to measure Novozymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes is operating at the current time. Most of Novozymes' value examination focuses on studying past and present price action to predict the probability of Novozymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes' price. Additionally, you may evaluate how the addition of Novozymes to your portfolios can decrease your overall portfolio volatility.